Election 2014
SENSEX NIFTY

Sun Learning Services

Apr 07, 2014 at 16:35 | Source: CNBC-TV18
Ambareesh Baliga, Managing Partner-Global Wealth Management at Edelweiss Financial Services recommends holding Sun Pharmaceutical Industries with a target of Rs 650-680.
Apr 07, 2014 at 08:52 | Source: CNBC-TV18
Sun Pharma | Ranbaxy Labs | Escorts | SBI | Gammon Infrastructure | Mercator | SAIL | Man Industries | Cairn India | Reliance Industries | Tata Steel and BHEL are stocks, which are in the news today.
Apr 04, 2014 at 10:24 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Ranbaxy Laboratories, Lupin, Dr Reddys Laboratories, Sun Pharmaceutical Industries, Wockhardt, Glenmark Pharma and Biocon will get astrological support.
Apr 01, 2014 at 10:40 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, technology stocks like Tata Consultancy Services, Tech Mahindra, Wipro, Sasken Communication Technologies and HCL Technologies will get strological support.
Mar 26, 2014 at 22:37 | Source: CNBC-TV18
Since the UPA-2 came to power, wealth creation on the NSE stands at 35 lakh crore rupees with the nifty gaining 80 percent. But in dollar terms, that's just a 47 percent jump, not something FIIs are thrilled about.
Mar 25, 2014 at 10:27 | Source: CNBC-TV18
Traders who are looking to play recovery in the capex cycle theme can buy infrastructure stocks, but from six months two years perspective, one should be cautious, Gautam Chhaochharia, head of India research of UBS Securities said.
Mar 25, 2014 at 09:58 | Source: Moneycontrol.com
Equity and Debt Mutual Funds surge on Monday, as the Equity benchmarks saw fresh all-time highs on Monday with the Sensex closing above the psychological 22000-mark, supported by strong Asian cues and FII flows
Mar 24, 2014 at 16:56 | Source: CNBC-TV18
According to Ambareesh Baliga, Managing Partner-Global Wealth Management at Edelweiss Financial Services, one may pick Sun Pharmaceutical Industries and Lupin.
Mar 14, 2014 at 14:49 | Source: CNBC-TV18
Devang Mehta of Anand Rathi Financial Services is of the view that one may buy Sun Pharmaceutical Industries as the stock may see an upside on 20-25 percent from current level.
Mar 13, 2014 at 10:53 | Source: Moneycontrol.com
According to Magnum Equity Broking, Nifty is expected to trade range-bound between 6570 and 6480 with positive biasness.
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.